Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT

Journal of Cell Biology

Volumn 159, Issue 6, 2002, Pages 1029-1037

  Baldanzi, Gianluca ^a   Filigheddu, Nicoletta ^a   Cutrupi, Santina ^a   Catapano, Filomena ^b   Bonissoni, Sara ^a   Fubini, Alberto ^b   Malan, Daniela ^b   Baj, Germano ^a   Granata, Riccarda ^c   Broglio, Fabio ^c   Papotti, Mauro ^b   Surico, Nicola ^a   Bussolino, Federico ^b   Isgaard, Jorgen ^d   Deghenghi, Romano ^e   Sinigaglia, Fabiola ^a   Prat, Maria ^a   Muccioli, Giampiero ^b   Ghigo, Ezio ^c   Graziani, Andrea ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e Ardana   (France)

Author keywords

Akt; Apoptosis; ERKs; Ghrelin; Heart

Indexed keywords

DES ACYL GHRELIN; GENE PRODUCT; GHRELIN; GROWTH HORMONE SECRETAGOGUE RECEPTOR; HEXARELIN; HORMONE DERIVATIVE; IBUTAMOREN; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; RECEPTOR SUBTYPE; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ACYLATION; ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; GUINEA PIG; HEART MUSCLE CELL; HEART PROTECTION; HORMONE BINDING; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; BINDING, COMPETITIVE; BLOTTING, WESTERN; CELL DEATH; CELL SEPARATION; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; ENZYME INHIBITORS; FLOW CYTOMETRY; INDOLES; INHIBITORY CONCENTRATION 50; MICROSCOPY, PHASE-CONTRAST; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; OLIGOPEPTIDES; PEPTIDE HORMONES; PEPTIDES; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPIRO COMPOUNDS; SWINE; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0037164747     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200207165     Document Type: Article

References (39)

1. Alessi, D.R., M. Andjelkovic, B. Caudwell, P. Cron, N. Morrice, P. Cohen, and B.A. Hemmings. 1996. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15:6541-6551.
2. Arola, O.J., A. Saraste, K. Pulkki, M. Kallajoki, M. Parvinen, and L.M. Voipio-Pulkki. 2000. Acute doxorubicin cardioroxicity involves cardiomyocyte apoptosis. Cancer Res. 60:1789-1792.
3. Bisi, G., V. Podio, M.R. Valetto, F. Broglio, G. Bertuccio, G. Aimaretti, E. Pelosi, G. Del Rio, G. Muccioli, H. Ong, et al. 1999. Cardiac effects of hexarelin in hypopituitary adults. Eur. J. Pharmacol. 381:31-38.
4. Bodart, V., M. Febbraio, A. Demers, N. McNicoll, P. Pohankova, A. Perreault, T. Sejlitz, E. Escher, R.L. Silverstein, D. Lamontagne, and H. Ong. 2002. CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. Circ. Res. 90:844-849.
5. Bowers, C.Y. 2001. Unnatural growth hormone-releasing peptide begets natural ghrelin. J. Clin. Endocrinol. Metab. 86:1464-1469.
6. Buerke, M., T. Murohara, C. Skurk, C. Nuss, K. Tomaselli, and A.M. Lefer. 1995. Cardio protective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc. Natl. Acad. Sci. USA. 92:8031-8035.
7. Cassoni, P., M. Papotti, C. Ghe, F. Catapano, A. Sapino, A. Graziani, R. Deghenghi, T. Reissmann, E. Ghigo, and G. Muccioli. 2001. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J. Clin. Endocrinol. Metab. 86:1738-1745.
8. Chen, S., D.C. Guttridge, E. Tang, S. Shi, K. Guan, and C.Y. Wang. 2001. Suppression of tumor necrosis factor-mediated apoptosis by nuclear factor kappaB-independent bone morphogenetic protein/Smad signaling. J. Biol. Chem. 276:39259-39263.
9. Cutrupi, S., G. Baldanzi, D. Gramaglia, A. Maffe, D. Schaap, E. Giraudo, W. van Blitterswijk, F. Bussolino, P.M. Comoglio, and A. Graziani. 2000. Srcmediated activation of alpha-diacylglycerol kinase is required for hepatocyte growth factor-induced cell motility. EMBO J. 19:4614-4622.
10. Filigheddu, N., A. Fubini, G. Baldanzi, S. Cutrupi, C. Ghe, F. Catapano, F. Broglio, A. Bosia, M. Papotti, G. Muccioli, et al. 2001. Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death. Endocrine. 14(1):113-119.
11. Gallo, M.P., D. Malan, I. Bedendi, C. Biasin, G. Alloatti, and R.C. Levi. 2001. Regulation of cardiac calcium current by NO and cGMP-modulating agents. Pflugers Arch. 441:621-628.
12. Gnanapavan, S., B. Kola, S.A. Bustin, D.G. Morris, P. McGee, P. Fairclough, S. Bhattacharya, R. Carpenter, A.B. Grossman, and M. Korbonits. 2002. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans, J. Clin. Endocrinol. Metab. 87:2988.
13. Hayakawa, K., G. Takemura, M. Koda, Y. Kawase, R. Maruyama, Y. Li, S. Minatoguchi, T. Fujiwara, and H. Fujiwara. 2002. Sensitivity to apoptosis signal, clearance rate, and ultrastructure of fas ligand-induced apoptosis in in vivo adult cardiac cells. Circulation. 105:3039-3045.
14. Hirota, H., J. Chen, U.A. Betz, K. Rajewsky, Y. Gu, J. Ross, Jr., W. Muller, and K.R. Chien. 1999, Loss ofa gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell. 97:189-198.
15. Hosoda, H., M. Kojima., H. Matsuo, and K. Kangawa. 2000. Ghrelin and des-acyl ghrelin: Two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem. Biophys. Res. Comm. 279:909-913.
16. Howard, A.D., S.D. Feighner, D.F. Cully, J.P. Arena, P.A. Liberator, C.I. Rosenblum, M. Hamelin, D.L. Hreniuk, O.C. Palyha, J. Anderson, et al. 1996. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 273:974-977.
17. Inu, A. 2001. Ghrelin: An orexigenic and somatotrophic signal from the stomach. Nat. Rev. Neurosci. 2:551-560.
18. Jeremias, I., C Kupatt, A. Martin-Villalba, H. Habazettl, J. Schenkel, P. Boekstegets, and K.M. Debatin. 2000. Involvement of CD95/Apol/Fas in cell death after myocardial ischemia. Circulation. 102:915-920.
19. Katugampola, S.D., Z. Pallikaros, and A.P. Davenport. 2001. [1251-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: Up-regulation of receptors with athersclerosis. Br. J. Pharmacol. 134:143-149.
20. King, M.K., D.M. Gay, L.C. Pan, J.H. McElmurray, III, J.W. Hendrick, C. Pirie, A. Morrison, C. Ding, R. Mukherjee, and F.G. Spinale. 2001. Treatment with a growth hormone secretagogue in a model of developing heart failure: Effects on ventricular and myocyte function. Circulation. 103:308-313.
21. Kojima, M., H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa. 1999. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 402:656-660.
22. Locatelli, V., G. Rossoni, F. Schweiger, A. Torsello, V. De Gennaro Colonna, M. Bernareggi, R. Deghenghi, E.E. Muller, and F. Berti. 1999. Growth hormone-independent cardioprotective effects of hexarelin in the rat. Endocrinology. 140:4024-4031.
23. 125I-labeted ghrelin to membranes from human hypothalamus and pituitary gland. J. Endocrinol. Invest. 24:RC7-RC9.
24. Muccioli, G., M. Tschöp, M. Papotti, R. Deghenghi, M. Heiman, and E. Ghigo. 2002. Neuroendocrine and peripheral activities of ghrelin: Implications in metabolism and obesity. Eur. J. Pharmacol. 440:235-254.
25. Murata, M., Y. Okimura, K. Iida, M. Matsumoto, H. Sowa, H. Kaji, M. Kojima, K. Kangawa, and K. Chihara. 2002. Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J. Biol. Chem. 277:5667-5674.
26. Nagaya, N., M. Kojima, M. Uematsu, M. Yamagishi, H. Hosoda, H. Oya, Y. Hayashi, and K. Kangawa. 2001a. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280:R1483-R1487.
27. Nagaya, N., M. Uematsu, M. Kojima, Y. Ikeda, F. Yoshihara, W. Shimizu, H. Hosoda, Y. Hirota, H. Ishida, H. Mori, and K. Kangawa. 2001b. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation. 104:1430-1435.
28. Nakamura, T., Y. Ueda, Y. Juan, S. Katsuda, H. Takahashi, and E. Koh. 2000. Fas-mediated apoptosis in adriamycin-induced cardiomyopathy in rats: In vivo study. Circulation. 102:572-578.
29. Nakazato, M., N. Murakami, Y. Date, M. Kojima, H. Matsuo, K. Kangawa, and S. Matsukura. 2001. A role for ghrelin in the central regulation of feeding. Nature. 409:194-198.
30. Okumura, H., N. Nagaya, M. Enomoto, E. Nakagawa, H. Oya, and K. Kangawa. 2002. Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. J. Cardiovasc. Pharmacol. 39:779-783.
31. Papotti, M., C. Ghe, P. Cassoni, F. Catapano, R. Deghenghi, E. Ghigo, and G. Muccioli. 2000. Growth hormone secretagogue binding sites in peripheral human tissues. J. Clin. Endocrinol. Metab. 85:3803-3807.
32. Parrizas, M., A.R. Saltiel, and D. LeRoith. 1997. IGF-1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J. Biol. Chem. 272:154-161.
33. Rios, R., I. Carneiro, V.M. Arce, and J. Devesa. 2001. Myostatin regulates cell survival during C2C12 myogenesis. Biochem. Biophys. Res. Commun. 280:561-566.
34. Takemura, G., S. Kato, T. Aoyama, Y. Hayakawa, M. Kanoh, R. Maruyama, M. Arai, K. Nishigaki, S. Minatoguchi, K. Fukuda, et al. 2001. Characterization of ultrastructure and its relation with DNA fragmentation in Fas-induced apoptosis of cultured cardiac myocytes. J. Pathol. 193:546-556.
35. Tivesren, A., E. Bollano, K. Caidahl, V. Kujacic, X.Y. Sun, T. Hedner, A. Hjalmarson, B.A. Bengtsson, and J. Isgaard. 2000. The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction. Endocrinology. 141:60-66.
36. Torsello, A., C. Ghè, E. Bresciani, F. Catapano, E. Ghigo, R. Deghenghi, V. Locatelli, and G. Muccioli. 2002. Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo. Endocrinology. 143:1968-1971.
37. Tschop, M., D.L. Smiley, and M.L. Heiman. 2000. Ghrelin induces adiposity in rodents. Nature. 407:908-913.
38. Wu, W., W.L. Lee, Y.Y. Wu, D. Chen, T.J. Liu, A. Jang, P.M. Sharma, and P.H. Wang. 2000. Expression of constitutively active phosphatidylinositol 3-kinase inhibits activation of caspase 3 and apoptosis of cardiac muscle cells. J. Biol. Chem. 275:40113-40119.
39. Yamamura, T., H. Nakamura, T. Yamamoto, S. Umemoto, T. Fujii, N. Kobayashi, and M. Matsuzaki. 1999. Fas expression and apoptosis correlate with cardiac dysfunction in patients with dilated cardiomyopathy. Jpn. Circ. J. 63:149-154.